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Photoswitchable fatty acids enable optical
control of TRPV1
James Allen Frank1, Mirko Moroni2, Rabih Moshourab2,3, Martin Sumser1, Gary R. Lewin2 & Dirk Trauner1
Fatty acids (FAs) are not only essential components of cellular energy storage and structure,
but play crucial roles in signalling. Here we present a toolkit of photoswitchable FA analogues
(FAAzos) that incorporate an azobenzene photoswitch along the FA chain. By modifying the
FAAzos to resemble capsaicin, we prepare a series of photolipids targeting the Vanilloid
Receptor 1 (TRPV1), a non-selective cation channel known for its role in nociception. Several
azo-capsaicin derivatives (AzCAs) emerge as photoswitchable agonists of TRPV1 that are
relatively inactive in the dark and become active on irradiation with ultraviolet-A light. This
effect can be rapidly reversed by irradiation with blue light and permits the robust optical
control of dorsal root ganglion neurons and C-fibre nociceptors with precision timing and
kinetics not available with any other technique. More generally, we expect that photolipids
will find many applications in controlling biological pathways that rely on protein–lipid
interactions.
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L
ipids serve not only as sources of energy and integral
components of membranes but are also involved in cellular
communication through participation in a variety of
signalling cascades and the modulation of transmembrane
proteins1. Over the past several decades, interest in lipid
chemistry has been overshadowed by advancements in
proteomic and genomic technologies. However, recent
developments in lipid research, including analysis of the
lipidome2, have shed new light on the roles of these molecules
at all levels of biology. Many lipids consist of fatty acids (FAs).
These ancient molecular building blocks typically feature a long
linear carbon chain (up to 28 carbons)3 that often contains one or
several cis- double bonds.
The Vanilloid Receptor 1 (TRPV1) is the most studied of the
transient receptor potential ion channels4,5. This family of non-
selective cation channels is renowned for its ability to respond to
a wide variety of chemical and physical inputs6,7. TRPV1 is
involved in the regulation of body temperature8 and the
transduction of painful stimuli from the periphery towards the
central nervous system9. It is expressed in sub-populations of
sensory nerve fibres within the dorsal root and trigeminal
ganglia10, where it responds to temperatures greater than 43 C11,
protons12, as well as environmental toxins and poisons13,14.
Importantly, TRPV1 is modulated by a plethora of FA amides,
including the endogenous arachidonic acid derivatives
anandamide15 and N-arachidonoyl dopamine16. Its most
famous exogenous agonist is the vanilloid capsaicin (CAP), the
pungent component of chilli peppers11. Synthetic TRPV1
agonists include olvanil17 and arvanil18, which are FA-derived
vanilloids developed as non-pungent CAP analogues.
TRPV1 is not only involved in responses to noxious stimuli,
but is also believed to initiate the neurogenic inflammatory
response19, which has made it an attractive target for novel
analgesics11. However, these attempts have proven more
challenging than anticipated, as TRPV1 is involved in a variety
of other biological pathways that can lead to unwanted side
effects. An agonist or antagonist that could be applied globally but
activated only locally could offer a solution to this problem. In
addition to this, such a tool would be highly valuable for
untangling the complex interactions that TRPV1 has with other
proteins, such as the serotonin (5-HT), bradykinin (BK) and
recently GABAB receptors5,20,21.
Precision control can be achieved through photoswitchable
small molecules that act as transducers between a light stimulus
and protein function22–24. In 2013, our group was the first to
place TRPV1 under reversible optical control when we developed
a series of photoswitchable antagonists which could optically
control TRPV1 in the presence of CAP to activate the channel25.
Based on the structure of CAP and other TRPV1 agonists, we saw
the opportunity to develop a photoswitchable TRPV1 agonist
which would permit optical control over the ion channel without
the use of a second factor.
In this study, we present a toolkit of photolipids that allow us
to place lipid-modulated biological targets, such as TRPV1, under
the precise spatial and temporal control of light. We show that
AzCA4 permits optical control over TRPV1 in complex neural
systems with a higher degree of spatiotemporal precision than is
currently possible via other methods. More generally, this work
represents the first example of the fusion of photopharmacology
with lipid signalling and consequently sets the groundwork for
future research in this field.
Results
Photolipid syntheses. In an effort to mimic FAs with a chain
length of 18 carbons, we prepared a series of 8 photoswitchable
FA derivatives, FAAzo1–8. Each of these compounds contained
an azobenzene photoswitch, which allowed for controllable
cis/trans-isomerization along the length of the chain (Fig. 1a).
FAAzo1–8 were prepared in between two and six steps
in moderate yield (Supplementary Fig. 1)26. In their dark-adapted
state, the FAAzos existed predominantly in the trans-
configuration. Ultraviolet–visible spectroscopy showed that
isomerization from trans- to cis- could be achieved by
irradiation at l¼ 365 nm and this process could be reversed by
l¼ 460 nm light.
Supported by structure–activity relationships and recent
structural data27, we envisioned a unique opportunity to create
a series of photoswitchable vanilloids for the optical control of
TRPV1. Our approach combined the vanilloid head group of
CAP with the FAAzos, which would act as a photoswitchable
tail mimicking that of N-arachidonoyl dopamine, anandamide,
olvanil or arvanil (Fig. 1b). The preparation of these compounds
(Fig. 1c and Supplementary Fig. 2) required only a peptide
coupling between vanillamine and the appropriate FAAzo to
afford eight photoswitchable vanilloids, AzCA1–8, in good yields
(Fig. 1b). Photoswitching of AzCA1–8 was also achieved using
l¼ 365/460 nm and they showed similar photoswitching
properties when compared with the FAAzos (Supplementary
Fig. 3). As such, both FAAzos and AzCAs could be classified
as ‘regular’ azobenzenes that require ultraviolet-A light for
isomerization to their thermally unstable cis-form.
Optical control over TRPV1 in HEK293T cells. We evaluated
the photopharmacology of AzCA1–8 using whole-cell electro-
physiology in human embryonic kidney (HEK) 293T cells
transiently expressing the yellow fluorescent protein (YFP)-tag-
ged ion channel (TRPV1-YFP)28. Each compound (1 mM) was
continuously applied while alternating between irradiation at
l¼ 350 nm and at l¼ 450 nm, until a steady state of activity/
desensitization was achieved on photoswitching. Their relative
light-dependant activities were then assessed by performing
voltage ramps ( 100 to þ 100mV over 5 s) under irradiation at
both wavelengths (Fig. 2a and Supplementary Fig. 4a). Among
the eight derivatives tested, three compounds—AzCA2, AzCA3
and AzCA4 (at 1mM)—showed the most profound TRPV1
photoswitching effect (Fig. 2b and Supplementary Fig. 4b). For all
three derivatives, larger currents were observed under irradiation
at l¼ 350 nm, indicating that these compounds had higher
efficacies towards TRPV1 in their cis-configuration. At higher
concentrations (4300 nM, bath application), smaller cellular
currents were observed on application of the AzCAs in their
dark-adapted states. This showed that in both configurations, the
AzCAs were TRPV1 agonists; however, in all cases a larger
current was observed under l¼ 350 nm irradiation. Working at
an optimized concentration (1 mM by puff pipette), the AzCAs
could be applied to cells in the dark without any observable effect
and this allowed immediate TRPV1 activation on irradiation with
ultraviolet-A light (Supplementary Fig. 5). Photoswitching could
be repeated over multiple cycles and only minor channel
desensitization was observed (Fig. 2c).
The washout of AzCA4 with buffer was very slow and
photoswitching currents persisted for minutes under constant
perfusion. However, application of capsazepine (5 mM), a TRPV1
antagonist known to bind competitively against CAP, was capable
of displacing AzCA4 and rapidly abolished inward currents on
ultraviolet stimulation (Supplementary Fig. 6)29,30. In control
experiments, no light-induced activity was observed in cells
lacking TRPV1, before the application of an AzCA derivative
(Supplementary Fig. 7a) or after the application of CAP (1 mM)
(Supplementary Fig. 7b). The application of FAAzo2, FAAzo3
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8118
2 NATURE COMMUNICATIONS | 6:7118 | DOI: 10.1038/ncomms8118 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
and FAAzo4 caused no effect (5 mM, nZ3 for each) in TRPV1-
responding cells.
In voltage clamp experiments, the magnitude of the cellular
currents could be controlled by adjusting the ON wavelength
between l¼ 350–390 nm. As shown by an action spectrum, the
largest currents were observed under l¼ 350 nm and they
became smaller towards l¼ 390 nm (Fig. 3a and Supplementary
Fig. 8). Current clamp experiments revealed that the cellular
membrane potential could be controlled in a similar manner, with
l¼ 360 nm yielding the largest depolarization (Fig. 3b). Through
exponential curve fitting, we evaluated the effects of irradiation
on the TRPV1 activation kinetics. The fastest ON response was
observed at l¼ 360 nm and all other ton values were normalized
to this t-value for comparison (Fig. 3c). At longer wavelengths, a
slower response was observed. Taken together, these results
indicate that the AzCAs permit precise, optical control over the
activity of TRPV1 that cannot be achieved with other lipophilic
agonists, such as CAP, alone. As AzCA4 could be prepared in
high yield at low cost, we decided to focus our future
investigations on this compound.
AzCA4 allowed optical control over cultured DRG neurons.
Having demonstrated that AzCA4 acts as a photoswitchable
TRPV1 agonist that is relatively inactive in the dark, we next
evaluated its activity in isolated wild-type (wt) mouse dorsal root
ganglia (DRG) neurons using both electrophysiology and intra-
cellular Ca2þ imaging.
Whole-cell patch clamp electrophysiology showed that AzCA4
(200 nM) enabled reversible optical control over DRG neuronal
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activity. Switching between l¼ 365 nm and l¼ 460 nm in the
voltage clamp configuration at a holding potential of  60mV
resulted in reversible control over the transmembrane currents
(Fig. 4a). Accordingly, the membrane potential and excitability of
DRG neurons could be optically controlled as well. Action
potential (AP) firing was reversibly switched ON and OFF
by irradiation with l¼ 365 nm and l¼ 460 nm, respectively
(Fig. 4b).
Bath application of AzCA4 (100 nM) and irradiation at
l¼ 365 nm (5 s) caused an increase in intracellular Ca2þ
concentration in B30% of DRG neurons cultured from 2- to
3-week-old mice (Fig. 4c and Supplementary Fig. 9). The
remaining 70% of the DRG neurons did not respond to
AzCA4 but still responded to a high potassium (Hi-Kþ ) solution
(100mM) (Fig. 4d). The percentage of AzCA4 responding
neurons was consistent with the percentage of TRPV1 containing
DRG neurons at this stage of mouse development (33.6±1.3%
at P15, 30.5±3% at P22)31.
AzCA4 is selective for TRPV1-expressing neurons in the DRG.
TRPV1 knockout mutant mice (Trpv1 / ) have proven to be an
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excellent negative control to study the functional aspects of
TRPV1 and the role of CAP-sensitive afferent neurons in the
mammalian nervous system32. We used this mouse line to assay
the selectivity of AzCA4 in DRG neurons. As expected, Ca2þ
imaging in Trpv1 / mouse DRG neurons showed no neural
activity in response to AzCA4 (300 nM) or CAP (300 nM).
Control experiments showed that these neurons still responded to
menthol (100 mM, data not shown), ATP (20 mM) and Hi-Kþ
(100mM) solutions (Supplementary Fig. 10). In combination,
these results indicate that AzCA4 acted solely on TRPV1-positive
neurons in the DRG.
Optical control of C-fibre nociceptors. We next evaluated the
effects of AzCA4 on heat-sensitive C-fibre nociceptors (C-MH) in
the ex vivo skin nerve preparation of the saphenous nerve. In wt
mice, 19 out of 35 C-MH responded to AzCA4 photoswitching
compared with none of the 11 C-MH examined in Trpv1 /
mice (Po0.001, w2-test; Fig. 5a). We compared the activation of
AzCA4 with that of CAP on C-MH in terms of the latency time to
the first AP spike, as well as the AP discharge rates. Peak dis-
charge rates during photostimulation with l¼ 365 nm surged
rapidly to 9.6 spikes per second and lasted on average 11.0±6.9 s
(Fig. 5b). The average peak discharge rates of C-MH due to
AzCA4 photoswitching were not significantly different from CAP
stimulation (Fig. 5c). However, the mean latency time to the first
AP spike on irradiation with l¼ 365 nm in the presence of
AzCA4 was significantly shorter (1.9±0.5 s; mean±s.e.m.) when
compared with the latencies to the first spike after CAP appli-
cation (9.5±3.5 s) (Fig. 5d, Mann–Whitney test, Po0.05). The
discharges of C-MH in response to AzCA4 were usually transient
and adapted during the 20 s photostimulation period. These
responses were completely reproducible after a 5min recovery
interval, during which AzCA4 was kept on the receptive field with
no signs of desensitization (Fig. 5e). Therefore, the photo-
switching of AzCA4 could selectively activate TRPV1 receptors
on the peripheral terminals of cutaneous C-MH to a similar
magnitude as CAP. Advantageously, AzCA4 had the ability to
trigger a more rapid neuronal response and did not require
washout of the drug.
Serotonin and BK sensitized DRG neurons to AzCA4. TRPV1-
mediated hyperalgesia is a complex process, which underlies
inflammatory pain19,33. At sites of tissue injury, a number of
chemical agents are released, which cause an inflammatory
response resulting in an increased thermal pain sensation in
response to normally non-painful stimuli. Several G protein-
coupled receptors (GPCRs) mediate TRPV1 sensitization33,34.
BK- and 5-HT-triggered GPCR cascades are able to decrease the
threshold for TRPV1 activation and increase the number of
receptors at the cell surface5,33,35,36.
We used intracellular Ca2þ imaging in cultured wt mouse
DRG neurons to determine whether these endogenous inflam-
matory agents still sensitized TRPV1 towards AzCA4. Our
experiments showed that TRPV1 became sensitized to AzCA4
(200 nM) after the application of both BK (200 nM) and 5-HT
(100 mM) (Fig. 6a,b). After 5 pulses of AzCA4 and ultraviolet
irradiation, a steady state of TRPV1 desensitization was reached
and the cells were washed with the sensitizing agent for 5min
(Fig. 6a). In both cases, a final pulse of AzCA4 and ultraviolet
irradiation resulted in increased levels of intracellular Ca2þ when
compared with the previous pulse. Experiments with both
inflammatory agents produced similar results to those achieved
when using CAP as the channel agonist (Fig. 6b and
Supplementary Fig. 11). These results suggest that AzCA4 could
be used as a tool to study the involvement of TRPV1 in
inflammatory pain.
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AzCA4 is compatible with genetic tools. Genetically encoded
Ca2þ indicators, such as GCaMP3 (ref. 37), have proven very
useful for the study of neuronal activity in vitro and in vivo. We
therefore tested the ability of AzCA4 to work in combination with
this genetic tool. We crossed a mouse line that expresses the Cre
recombinase under the promoter of TRPV1 (ref. 38), with a
reporter mouse line that expresses GCaMP3 in a Cre-dependant
manner (Trpv1Cre/GCaMP3). As the majority of DRG neurons
express TRPV1 at embryonic stage E14.5 (ref. 31), we observed
that 90% of the DRG neurons in culture showed a faint basal
fluorescence, confirming that recombination had occurred in
most neurons at an earlier developmental stage.
However, on application of CAP or AzCA4 alongside
ultraviolet irradiation, only 30% of the neurons showed a
Ca2þ -dependent increase in fluorescence. This confirmed
not only the correct function and localization of GCaMP3 in
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TRPV1-positive DRG neurons, but also that this small molecular
photoswitch, AzCA4, can be used in combination with a genetic
tool.
To further confirm the applicability of AzCA4 and the use of
genetically encoded Ca2þ indicators to address physiologically
relevant issues, we repeated the sensitization experiments on the
Trpv1Cre/GCaMP3 mouse line (Fig. 6b, orange). These results again
confirmed that TRPV1 could be sensitized to AzCA4 by BK or
5-HT, even in the Trpv1Cre/GCaMP3 mouse line.
QX-314 can be selectively transported into DRG neurons.
QX-314 is a permanently charged lidocaine derivative that blocks
Naþ channels from the intracellular side but is unable to pene-
trate the plasma membrane due to its charged nature39. It has
been shown that QX-314, and its photoswitchable derivative
QAQ40, could be shuttled into cells via TRPV1 when co-applied
with CAP, to open the channel41. We hypothesized that
intracellular Ca2þ build-up is not only caused by Ca2þ influx
through TRPV1 but is a consequence of AP firing leading to
Ca2þ release from intracellular stores. We showed AzCA4
(200 nM) in combination with l¼ 365 nm irradiation, opened
TRPV1 and allowed QX-314 to enter TRPV1-positive neurons in
the DRG. The cells were first washed with a Hi-Kþ solution
(40mM) causing massive electrical activity. After the cells
recovered, four pulses of AzCA4 (200 nM, 5 s at l¼ 365 nm)
reached a steady state of TRPV1 desensitization. Next, AzCA4
was co-applied with QX-314 (5mM), followed by another pulse
of AzCA4 and a final pulse of the Hi-Kþ solution. By comparing
the peak heights of the first and final Hi-Kþ pulses (HK1 and
HK2, respectively), we observed that the cells that were responsive
to AzCA4 showed a lower HK2/HK1 ratio when compared with
cells that did not respond to AzCA4 (Fig. 7). These results
indicate that in combination with AzCA4, TRPV1 could be
used as an import channel to localize a charged anaesthetic in
TRPV1-positive cells, only.
Discussion
In this study, we present eight photoswitchable FAs, the
FAAzos. We expect that these lipophilic modules will allow
us to place a variety of lipid-modulated biological targets under
photopharmacological control. The FAAzos are FAs mimetics,
resembling in particular highly unsaturated FAs such as
arachidonic acid. These compounds could be used as molecular
building blocks for the construction of more complicated
photolipids, which could facilitate the optical control of a
wide range of ion channels, GPCRs and enzymes associated
with FA signalling.
We hypothesized that an azobenzene photoswitch would be
best suited towards integration into the FA backbone, as its
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6/Peak 5 for the wt mouse as follows: CAP with no sensitization agent (n¼ 520); CAP with BK (n¼ 210); CAP with 5-HT (n¼ 175); AzCA4 with no
sensitizing agent (n¼ 36); AzCA4 with BK (n¼ 15); and AzCA4 with 5-HT (n¼ 12). For the Trpv1Cre/GCaMP3 mouse line, the results are plotted for the
following: AzCA4 with BK (n¼ 28) and AzCA4 with 5-HT (n¼ 10). Error bars were calculated as s.e.m.
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Figure 7 | QX-314 could be shuttled into TRPV1-positive DRG neurons
using AzCA4. After the co-application of AzCA4 (200nM) and QX-314
(5mM), the peak heights of the Ca2þ signals of the Hi-Kþ (40mM)
pulses before (HK1) and after (HK2) drug application were compared. The
results were plotted as the peak height ratio of two pulses, HK2/HK1,
calculated for both AzCA4 responding and AzCA4 non-responding
neurons. The error bars were calculated as s.e.m.
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hydrophobic nature may cause only a minimal disruption to the
properties of a natural aliphatic chain. The FAAzos allow the
position of the switch to be fine-tuned to complement structure–
activity relationships between the ligand and its target. As a first
installment illustrating this concept, we showed that the FAAzos
could be incorporated into other photolipids through a simple
amide coupling reaction. In HEK293T cells, three AzCAs stood
out as the most promising candidates to enable the optical control
of TRPV1 and showed significant, light-dependant efficacy at
concentrations as low as 100 nM. All three compounds were more
potent in their cis-configuration. Owing to the structural
similarities between the AzCAs and other vanilloid TRPV1
agonists, we presume that the AzCAs act on the same vanilloid
binding site as CAP, olvanil and arvanil. This is further supported
by the requirement of the vanilloid headgroup, as was shown by
the inactivity of FAAzo2–4. Channel activation by AzCA4 can
also be completely blocked by the application of capsazepine, a
known competitive antagonist for CAP, suggesting a common
binding site and mode of activation.
We then demonstrated that AzCA4 was a powerful
modulator of DRG neurons in wt mice and the Trpv1Cre/GCaMP3
mouse line. Control experiments in untransfected HEK293T cells
and Trpv1 / mice showed no response to AzCA4, even on
light stimulation. These results rule out the possibility of
action through off-target mechanisms. This characteristic is
essential for the study of signal transduction in the nociceptive
neurons involved in inflammatory pain. To this end, we
envision that AzCA4 could be used to study TRPV1-mediated
hyperalgesia and the physiological processes involved with the
inflammatory state that occurs at sites of tissue injury. We
showed that application of components of the so-called
‘inflammatory soup’, such as BK or 5-HT, could sensitize TRPV1
to AzCA4 in DRG neurons. Furthermore, we proved that AzCA4
could be used in conjunction with genetic tools such as the
GCaMP3 Ca2þ indicator selectively expressed in TRPV1-positive
mouse neurons.
Importantly, AzCA4 allowed for greater temporal control over
TRPV1 than that which can be achieved by other small-molecule
agonists such as CAP, olvanil and arvanil. By working at an
optimized concentration, AzCA4 showed no activity towards
TRPV1 in its trans-configuration, but rapid TRPV1 activation
was observed when it was isomerized to its cis-configuration. This
ON and OFF effect became even more pronounced in neuronal
systems when the nonlinear, ‘all or nothing,’ nature of the AP
took effect. Previous studies have suggested that the rate of
TRPV1 activation determines the balance between agonist
potency and pungency42–45. Molecular weight and lipophilicity
normally define the pharmacodynamics of TRPV1 agonists42,43.
In the case of AzCAs, light provides another level of control. We
showed that the magnitude and rate of cellular activation could be
precisely tuned by adjusting the ON wavelength between l¼ 350
and 390 nm. Therefore, AzCAs could provide a platform for the
further understanding of hyperalgesia and could lead to the
development of new anaesthetics.
When using CAP to stimulate C-fibres in the saphenous nerve,
a relatively slow increase in AP firing was observed (Fig. 5b,c).
This effect was probably caused by the time required for CAP to
diffuse through the skin and plasma membrane to reach the
vanilloid binding site46–48. We showed that AzCA4 could be
applied to neurons as its dark-adapted, relatively inactive
configuration. On isomerization, TRPV1 was activated and AP
firing was immediately observed. It is this characteristic that
makes AzCA4 a useful tool for the study of nociception, a process
that relies on the rapid transmission of noxious stimuli from the
periphery towards the coordinating centres of the central nervous
system. AzCA4 also possesses significant advantages when
compared with other small molecules that have been used to
place TRPV1 under the control of light. Caged CAP is a useful
tool that has increased the level of control with which we are able
to activate TRPV1 (ref. 49). However, compound uncaging and
TRPV1 activation is a non-reversible, one-shot process. Repeated
activation by uncaging relies on fast-acting transporters or
deactivating enzymes to clear the synapse of the free ligand50.
The fact that CAP and its analogues exhibit long-lasting
effects suggests that they do not undergo transporter-mediated
reuptake or significant enzymatic hydrolysis. These aspects are
circumvented by the use of AzCA4, which allows for successive
rounds of activation/inactivation without the requirement for
washout of the drug. Previously, we showed that photo-
switchable TRPV1 antagonists can optically control the activity
of a constitutively active agonist on photoswitching25. In
comparison, AzCA4 greatly simplifies this system and is
capable of activating TRPV1 directly. This permits the optical
control of neuronal excitability without the use of a second factor.
Advantageously, AzCA4 is relatively inactive in the dark;
therefore, a more rapid and reproducible initiation of activity
can be achieved after it has distributed itself uniformly within
more complex tissues.
In conclusion, this study provides the first application of
photopharmacology to lipid signalling. Given the ubiquitous
distribution of FA derivatives at all levels of nature, we envision
that the FAAzos and their conjugates will emerge as broadly
applicable tools for the optical control of biological functions
which rely on protein–lipid interactions.
Methods
Whole-cell electrophysiology in HEK293T cells. HEK293T cells (obtained
from the Leibniz-Institute DSMZ: 305) were incubated at 37 C (10% CO2) in
DMEM mediumþ 10% fetal bovine serum and were split at 80%–90% confluency.
For cell detachment, the medium was removed and the cells were washed with
calcium-free PBS buffer and treated with trypsin for 2min at 37 C. The detached
cells were diluted in growth medium and plated on acid-etched coverslips coated
with poly-L-lysine in a 24-well plate. Cells (50,000) were added to each well in
500 ml standard growth medium along with the DNA (per coverslip: 500 ng
TRPV1–YFP28) and JetPRIME transfection reagents, according to the
manufacturer’s instructions (per coverslip: 50 ml JetPRIME buffer, 0.5 ml JetPRIME
transfection reagent). The transfection medium was exchanged for normal growth
media 4 h after transfection and electrophysiological experiments were carried out
20–40 h later. Whole-cell patch clamp experiments were performed using a
standard electrophysiology setup equipped with a HEKA Patch Clamp EPC10 USB
amplifier and PatchMaster software (HEKA Electronik). Micropipettes were
generated from ‘Science Products GB200-F-8P with filament’ pipettes using a
Narishige PC-10 vertical puller. The patch pipette resistance varied between 5 and
9MO. The bath solution contained the following: Solution A (in mM: 150 NaCl,
6.0 CsCl, 1.0 MgCl2, 1.5 CaCl2, 10 HEPES and 10 glucose (adjusted to pH 7.4 with
3M NaOH))51 or Solution B (in mM: 140 NaCl, 5 KCl, 5 HEPES, 1 MgCl and 5
glucose (adjusted to pH 7.4 with 3M NaOH)). The pipette solution contained th
following: Solution A’ (in mM: 150 NaCl, 3 MgCl2, 10 HEPES and 5 EGTA
(adjusted to pH 7.2 with 3M NaOH)) or solution B’ (in mM: 100K-gluconate,
40 KCl, 5 HEPES, 5 MgATP and 1 MgCl (adjusted to pH 7.2 with 1M KOH)). The
cells were first visualized to contain TRPV1–YFP by irradiation at l¼ 480 nm
using a Polychrome V (Till Photonics) monochromator. All cells had a leak
current between  15 to  300 pA on breakin at  60mV. All voltage clamp
measurements were carried out at a holding potential of  60mV. The cells
were held at 0 pA for current clamp measurements. The compounds were applied
by puff pipette using a ‘Toohey Spritzer pressure system IIe’ at 25 psi. The puff
pipette resistance varied between 3 and 5MO. All experiments were performed
at room temperature.
Determination of AzCA photoswitching properties. The photoswitching
properties of the prepared compounds were assessed using whole-cell voltage
clamp electrophysiology in HEK293T cells transiently expressing TRPV1–YFP28.
The compounds were dissolved as stock solutions in dimethylsulfoxide (DMSO;
2–6mM) and then diluted into warmed extracellular solution at a concentration of
1 mM. The cell was held at  60mV and voltage ramps ( 100 to þ 100mV over
5 s) were applied under both l¼ 450 nm and l¼ 350 nm irradiation. The AzCA
derivative (1 mM) was then constantly applied (puff pipette application) while
switching between the two wavelengths until a steady state of activity/
desensitization was observed on photoswitching (Supplementary Fig. 4a). The
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voltage ramps were applied again under each wavelength and the current change
(DI) between the baseline ( 60mV) and the ramp maximum (þ 100mV) was
recorded (Supplementary Fig. 4b). DI(350 nm) was normalized to DI(450 nm) and
this potentiation factor was averaged over multiple cells and plotted in Fig. 2b.
TRPV1 activation and inactivation kinetics were determined by exponential curve
fitting in Igor Pro.
Dorsal root ganglion neuronal culture. DRG were quickly dissected, collected in
ice-cold DRG medium and digested in 1mgml 1 Collagenase IV (Gibco) at 37 C
for 50min, to dissociate the tissue, followed by incubation in 0.05% trypsin (Gibco)
in PBS at 37 C for 15min. The trypsin was removed and cells were re-suspended
in 1ml of DRG medium. After gentle trituration, the DRGs were loaded onto a
2-ml BSA pillow and centrifuged at 250g for 10min, to separate the myelin and
debris. The resulting cell pellet was suspended in 50 ml fresh DRG medium
and plated onto poly-D-lysine (100 mgml 1) and laminin (10 mgml 1)-coated
coverslips. The cells were flooded with medium 30min after plating.
Whole-cell electrophysiology in cultured DRG neurons. Electrophysiological
recordings of DRG neurons from 14- to 21-day-old mice were performed using a
HEKA 10 amplifier (HEKA Instrument) and an ITC Analog Digital Converter
(HEKA) in whole-cell voltage clamp or current clamp configuration. The currents
were filtered with a built-in 5 kHz 8-pole Bessel filter and digitized at 50 kHz. The
currents were analysed using Clampfit 10.3 (Molecular Devices) and graphs
were plotted in Prism 5 (Graphpad). Experiments were performed 1–3 days after
plating. The Trpv1Cre and the GCaMP3 reporter mice were acquired from
Jackson Laboratory. DRG neurons were prepared for imaging from 25-week-old
Trpv1Cre/GCaMP3 mice.
The extracellular solution contained in mM: 150 NaCl, 5 KCl, 10 HEPES,
10 glucose, 2 CaCl2, 1 MgCl2. The intracellular solution contained (values in mM):
130 KCl, 10 HEPES, 10 EGTA, 1 CaCl2, 1 MgCl2, 2 MgATP, 1 NaGTP, 4 NaCl and
4 PhosphoCreatine.
Thick-walled electrodes (Harvard Apparatus, 1.17 0.87mm, external and
internal diameter, respectively) were pulled with a Sutter P-197 puller to a final
resistance of 3–5MO. After the breakthrough, the intracellular solution was
allowed to dialyse the intracellular medium for at least 1min before the beginning
of the recordings. Series resistance compensation reached values between 70 and
90%. Neurons were selected to have a leak current o 100 pA on breakin at
 60mV. All experimental procedures were carried out in accordance with the
State of Berlin Animal Welfare requirements and were approved by this authority.
Intracellular calcium imaging. DRG neurons plated on a 5-mm glass coverslip
were placed in a recording chamber of 300ml volume (Harvard Apparatus) and
were continuously perfused with extracellular solution at a rate of 2mlmin 1. The
wt neuron cells were loaded with Cal-520 (5mM, AAT-Bioquest) calcium dye for
1 h at 37 C in the presence of 0.02% pluronic acid dissolved in Ringer’s solution
(values in mM): 140 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 10 glucose,
adjusted to pH 7.4. CAP (100 nM, Tocris) was dissolved in extracellular solution
from a stock concentration of 10mM in ethanol. Fluorescent images were acquired
with Metafluor Software (Molecular Devices) and analysed in Clampfit. All
experiments were performed at room temperature. The dye excitation was per-
formed at l¼ 480 nm. The results were plotted as the change in fluorescence over
baseline fluorescence (DF/F) as a function of time (s).
Ex-vivo skin nerve preparation. The skin-nerve preparation was used as pre-
viously described, to record from single primary afferents52. Mice were killed with
CO2 inhalation for 2–4min, followed by cervical dislocation. The saphenous nerve
and the shaved skin of the hind limb were dissected free and placed in an organ
bath at 32 C. The chamber was perfused with a synthetic interstitial fluid (SIF
buffer) composed of (in mM): 123 NaCl, 3.5 KCl, 0.7 MgSO4, 1.7 NaH2PO4,
2.0 CaCl2, 9.5 Na-gluconate, 5.5 glucose, 7.5 sucrose and 10 HEPES at a pH of 7.4.
The skin was placed with the corium side up in the organ bath for pharmacological
application to the receptive fields of single sensory units. The saphenous nerve was
placed in an adjacent chamber on a mirror, and under microscopy fine filaments
were teased from the nerve and placed on the recording electrode. Electrical
isolation was achieved with mineral oil. Signals from the filaments were amplified
(Neurolog System, Digitimer Ltd) and sampled using a data acquisition system
(PowerLab 4.0, ADInstruments). The receptive fields of individual mechanically
sensitive C-fibre units were identified by manually probing the skin with the
blunted tip of a glass probe. Their conduction velocities (calculated by dividing
conduction distance over electrical latency for the first spike) were determined
using an electrical stimulator (1MO). All C-fibres studied were identified by
mechanical probing and were heat sensitive (C-MH). The conduction velocities
were in the C-fibre range (o1m s 1). The thermal sensitivity of identified C-fibres
was tested with a computer-controlled peltier device (3 5mm, Yale University
Medical School, Medical Instruments, New Haven, USA). A heat ramp was
delivered from 32 to 48 C at a rate of 1 C s 1 to the mechanically localized
receptive fields of single C-fibres. The receptive fields of heat-sensitive C-fibres
were isolated with a metal cylinder ring (5mm inner diameter, 10mm in height
and 1.44 g weight) for the administration of the drugs (AzCA4 or CAP). The metal
ring was tested for leakage before drug application. A stock solution of AzCA4 was
prepared in DMSO and diluted in SIF buffer. One hundred microlitres of a 1-mM
AzCA4 solution dissolved in SIF buffer was applied into the ring. The
pharmacological testing protocol with AzCA4 had four distinct successive phases:
(1) 60 s recording time before the application of AzCA4; (2) 60 s recording after
application of AzCA4; (3) 20 s of recording during photostimulation of AzCA4
with light-emitting diode (LED) light, l¼ 365 nm (Mic-LED-365, Prizmatix);
(4) 20 s of recording during photoinhibition of AzCA4 with LED light, l¼ 460 nm
(UHP-LED-460, Prizmatix). AzCA4 was kept in the ring for 300 s and a second
photostimulation with LED light 360 nm for 20 s was applied to test the
reproducibility of the initial responses. One hundred microlitres of CAP (1 mM,
Sigma) were administered onto the receptive field of another set of heat-sensitive
C-fibres for 20 s before washout. Recordings were obtained for 1min before and
2min after CAP administration. Spikes were discriminated offline, with the spike
histogram extension of the software. Data were obtained from six skin-nerve
preparations (2 Trpv1 / and 4 wt C57Bl/6 N mice). All experimental procedures
were carried out in accordance with the State of Berlin Animal Welfare
requirements and were approved by this authority.
Compound switching. Compound switching for electrophysiology in HEK293T
cells was achieved using a Polychrome V (Till Photonics) monochromator
(intensity versus wavelength screen Supplementary Fig. 12) and the light beam was
guided via a fibre-optic cable through the microscope objective and operated by the
amplifier and PatchMaster software (HEKA Electronik).
Compound switching for electrophysiology in DRG neurons was achieved using
a Prizmatix Mic-LED-365 high-power ultraviolet LED light source for illumination
at l¼ 365 nm and the Prizmatix UHP-Mic-LED-460 ultra-high-power LED light
source for illumination at l¼ 460 nm. The light beam was guided by a fibre-optic
cable and pointed directly towards the cells from above at an angle of about 45
from the side. The distance between the end of the cable and the cells was no
greater than 2 cm. Ultraviolet illumination during intracellular calcium imaging
was also performed using this light source.
Compound synthesis and characterization. All reagents and solvents were
purchased from commercial sources (Sigma-Aldrich, TCI Europe N.V., Strem
Chemicals and so on) and were used without further purification unless otherwise
noted. Tetrahydrofuran was distilled under a N2 atmosphere from Na/benzophe-
none before use. Triethylamine was distilled under a N2 atmosphere from CaH2
before use. Further dry solvents such as ethyl acetate, benzene, dichloromethane,
toluene, ethanol and methanol were purchased from Acros Organics as ‘extra dry’
reagents and used as received. Solvents were degassed by sparging the freshly
distilled solvent with argon gas in a Schlenk flask under ultrasonication using a
Bandelin Sonorex RK510H ultrasonic bath for 20min before use. Reactions were
monitored by thin-layer chromatography on pre-coated, Merck Silica gel 60 F254
glass-backed plates and the chromatograms were first visualized by ultraviolet
irradiation at 254 nm, followed by staining with aqueous ninhydrin, anisaldehyde
or ceric ammonium molybdate solution and finally gentle heating with a heat gun.
Flash silica gel chromatography was performed using silica gel (SiO2, particle size
40-63mm) purchased from Merck.
Ultraviolet visible spectra were recorded using a Varian Cary 50 Bio UV-Visible
Spectrophotometer with Helma SUPRASIL precision cuvettes (10mm light path).
All compounds were dissolved at a concentration of 25 mM in DMSO. Switching
was achieved using a Polychrome V (Till Photonics) monochromator (intensity
versus wavelength screen Supplementary Fig. 12). The illumination was controlled
using PolyCon3.1 software and the light was guided through a fibre optic cable with
the tip pointed directly into the top of the sample cuvette.
All NMR spectra were measured on a BRUKER Avance III HD 400 (equipped
with a CryoProbe). Multiplicities in the following experimental procedures are
abbreviated as follows: s, singlet; d, doublet; t, triplet; q, quartet; quint, quintet; sext,
sextet; hept, heptet; br, broad; m, multiplet. Proton chemical shifts are expressed in
parts per million (p.p.m., d scale) and are referenced to the residual protium
in the NMR solvent (CDCl3: d¼ 7.26, D6-DMSO: dH¼ 2.50). Carbon chemical
shifts are expressed in p.p.m. (d scale) and are referenced to the carbon resonance
of the NMR solvent (CDCl3: d¼ 77.16, D6-DMSO: d¼ 39.52). Note: owing
to the trans/cis isomerization of some compounds containing an azobenzene
functionality, more signals were observed in the 1H and 13C spectra than would be
expected for the pure trans-isomer. Only signals for the major trans-isomer are
reported; however, the identities of the remaining peaks were verified by two-
dimensional correlation spectroscopy, heteronuclear single quantum coherence
and heteronuclear multiple bond correlation experiments. The atom-numbering
system is defined as depicted in Supplementary Fig. 13. All relevant synthetic
details and NMR spectra can be found in Supplementary Figs 14–46 and the
Supplementary Methods.
Infrared spectra were recorded as neat materials on a PERKIN ELMER
Spectrum BX-59343 instrument. For detection, a SMITHS DETECTION
DuraSam-plIR II Diamond ATR sensor was used. The measured wave numbers are
reported in cm 1.
Low- and high-resolution electron ionization mass spectra were obtained on a
MAT CH7A mass spectrometer. Low- and high-resolution electrospray ionization
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mass spectra were obtained on a Varian MAT 711 MS instrument operating in
either positive or negative ionization modes.
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